US$ 25.17
bpc 157 parkinson's disease research Stable Gastric Pentadecapeptide as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System bpc-157 parkinson's disease BPC-157 -
Description
Administration of a medication forces a physiological reaction, even if that medication is body-identical, a new buzz term in the healthcare sector

Its promise is significant, but its place in clinical medicine will depend on future large-scale studies validating what decades of smaller trials have already suggested: that Epitalon may be a cornerstone in anti-aging and regenerative health.

Any discussion of interactions at this stage is therefore based on pharmacological reasoning and extrapolation from related, licensed GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide

PMC 3485949
